Biolase pays up to end long-running patent battle
This article was originally published in Clinica
Executive Summary
Dental laser firm Biolase has agreed to pay $3m in cash, $4.5m in stock and additional warrants to bring an end to an intellectual property dispute that dates back several years. With the payment, Biolase secures eight US and international patents, four of which had been asserted against it, from Diodem, a company that owns intellectual property that originated from a now-bankrupt predecessor.